Cantor Fitzgerald Maintains Neutral on Gilead Sciences, Lowers Price Target to $80
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Olivia Brayer has maintained a Neutral rating on Gilead Sciences (NASDAQ:GILD) and lowered the price target from $85 to $80.
July 20, 2023 | 1:43 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cantor Fitzgerald has maintained a Neutral rating on Gilead Sciences and lowered the price target from $85 to $80.
The news directly pertains to Gilead Sciences as Cantor Fitzgerald has maintained a Neutral rating on the company and lowered the price target. This could potentially impact investor sentiment and the stock's market performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100